Organon earnings call
Witryna11 lis 2024 · Organon & Co. (NYSE:NYSE:OGN) Q3 2024 Results Conference Call November 11, 2024 8:30 AM ETCompany ParticipantsKevin Ali – Chief Executive OfficerMatt Walsh – Chief Financial... WitrynaThis text should be viewed in conjunction with Organon’s Full Year/Q 4 2024 earnings call. 2. Safe Harbor for Forward- Looking Statements. Except for historical information …
Organon earnings call
Did you know?
WitrynaOrganon resources; Request for information; Media. Media overview; News releases; Company statements; Media library & contacts ... can we help you find? Search for: … Witryna3 lis 2024 · Transcript : Organon & Co., Q3 2024 Earnings Call, Nov 03, 2024. Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Organon Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder,...
Witryna30 cze 2024 · Organon will host a conference call at 8:30 a.m. Eastern Time today to discuss its second quarter 2024 financial results. To listen to the event and view the … Witryna14 kwi 2024 · Organon & Co. Stock Up 1.6 %. Shares of OGN opened at $23.98 on Friday. The company has a market capitalization of $6.10 billion, a price-to-earnings ratio of 6.68, a price-to-earnings-growth ratio of 0.99 and a beta of 0.76. Organon & Co. has a 52-week low of $20.96 and a 52-week high of $39.09.
Witryna4 sie 2024 · this call is being recorded. Thank you. I'd now like to turn the call over to Jennifer Halchak, Vice President of Investor Relations. Please begin your conference. ..... Jennifer Halchak Vice President-Investor Relations, Organon & Co. Thank you, Chantal. And good morning, everyone. Thank you for joining Organon's second quarter 2024 … Witryna12 sie 2024 · Other Ticker Details OGN Company Name Organon & Co Earnings Call Date 12-Aug-21 Time (ET) 08:30 AM Fiscal Quarter Q2 Fiscal Year 2024
Witryna16 lut 2024 · Organon & Co. (OGN ) Q4 2024 Earnings Call Corrected Transcript 16 -Feb -2024 1 -877 -FACTSET www.callstreet.com 2 Copyright © 2001 -2024 FactSet …
Witryna6 kwi 2024 · ORGANON & CO. company earnings calendar and analyst expectations - Upcoming and past events Börse Stuttgart: 7XP Börse Stuttgart. Advanced search ... FY 2024 Earnings Call: 02/16/23 07:30am : FY 2024 Earnings Release: 01/10/23 10:30am : JP Morgan Healthcare Conference - Fireside Chat: budget saver chocolate bananaWitryna17 lut 2024 · Organon & Co. (NYSE:NYSE:OGN) Q4 2024 Results Conference Call February 17, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - CEOMatt Walsh - CFOConference Call... budget saver ice creamWitryna9 kwi 2024 · Organon & Co. had a negative return on equity of 118.21% and a net margin of 14.85%. Organon & Co.'s revenue was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.37 earnings per share. Sell-side analysts forecast that Organon & Co. will post 4.31 EPS for the … crime stats by address freeWitryna3 lis 2024 · Organon & Co., Q3 2024 Earnings Call. November 3, 2024 8:30 am ET. Created with Sketch. Webcast. Organon Q3 2024 Financial Results. Organon Q3 … crime stats boston maWitryna10 kwi 2024 · Organon & Co. (NYSE:OGN - Get Rating) last announced its earnings results on Thursday, February 16th. The company reported $0.81 earnings per share for the quarter, missing the consensus estimate of $0.85 by ($0.04). Organon & Co. had a net margin of 14.85% and a negative return on equity of 118.21%. budget saver cherry pineappleWitryna17 lut 2024 · Vice President, Investor Relations at Organon & Co. Thank you, Mary. Good morning, everyone. And thank you for joining our fourth quarter and full year 2024 earnings call. With me today are Kevin Ali, Organon's Chief Executive Officer; and Matt Walsh, our Chief Financial Officer; Dr. Sandra Milligan, Organon's Head of R&D, will … budget saver locationsWitrynaOrganon 3rd Quarter Earnings Conference Call November 11, 2024 Page 3 26 Endometriosis is a high priority unmet need for us. It affects up to 170 million patients or up to 10% of all women of reproductive age. In current therapies and development, candidates target the pain associated with budget saver popsicle recall